Detalhe da pesquisa
1.
A blood-based immune marker for resistance to pembrolizumab in patients with metastatic urothelial cancer.
Cancer Immunol Immunother
; 72(3): 759-767, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35976415
2.
Lack of B and T cell reactivity towards IDH1R132H in blood and tumor tissue from LGG patients.
J Neurooncol
; 144(1): 79-87, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31240524
3.
MAGE-C2-Specific TCRs Combined with Epigenetic Drug-Enhanced Antigenicity Yield Robust and Tumor-Selective T Cell Responses.
J Immunol
; 197(6): 2541-52, 2016 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27489285
4.
TCRs genetically linked to CD28 and CD3ε do not mispair with endogenous TCR chains and mediate enhanced T cell persistence and anti-melanoma activity.
J Immunol
; 193(10): 5315-26, 2014 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25320284
5.
TCR gene transfer: MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 epitopes as melanoma-specific immune targets.
Clin Dev Immunol
; 2012: 586314, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22400038
6.
Gene Engineering T Cells with T-Cell Receptor for Adoptive Therapy.
Methods Mol Biol
; 2453: 209-229, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35622329
7.
Germline Variation in PDCD1 Is Associated with Overall Survival in Patients with Metastatic Melanoma Treated with Anti-PD-1 Monotherapy.
Cancers (Basel)
; 13(6)2021 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33803602
8.
T Cells Expressing a TCR-Like Antibody Selected Against the Heteroclitic Variant of a Shared MAGE-A Epitope Do Not Recognise the Cognate Epitope.
Cancers (Basel)
; 12(5)2020 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32429338
9.
Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancer.
J Immunother Cancer
; 8(2)2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33427690
10.
CD45RA+CCR7- CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumab.
J Immunother Cancer
; 7(1): 149, 2019 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31176366
11.
Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient.
J Immunother Cancer
; 4: 21, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27096098
12.
Targeting melanoma with immunoliposomes coupled to anti-MAGE A1 TCR-like single-chain antibody.
Int J Nanomedicine
; 11: 955-75, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27022262
13.
T cell receptor-engineered T cells to treat solid tumors: T cell processing toward optimal T cell fitness.
Hum Gene Ther Methods
; 25(6): 345-57, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25423330